Related Experiment Video

Updated: Oct 19, 2025

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy
09:18

Measurements of Motor Function and Other Clinical Outcome Parameters in Ambulant Children with Duchenne Muscular Dystrophy

Published on: January 12, 2019

10.5K

Patient-reported outcome measures and value-based medicine in paediatrics: a timely review

Yi Hua Tan1, Jia Xuan Siew2, Biju Thomas1

  • 1Respiratory Medicine Service, KK Women's and Children's Hospital, Singapore.

Singapore Medical Journal
|September 20, 2021
PubMed

Insights

Patient-reported outcome measures (PROMs) are essential for personalized healthcare. Implementing PROMs in pediatrics enhances patient-centered care and improves community health outcomes within value-based medicine frameworks.

Area of Science:

  • Health Services Research
  • Pediatric Health
  • Value-Based Medicine

Background:

  • Healthcare is shifting towards personalized, patient-centric models emphasizing value.
  • Patient-reported outcome measures (PROMs) capture patient perceptions of health and quality of life over time.
  • PROMs are crucial for value-driven healthcare systems and practicing value-based medicine.

Purpose of the Study:

  • To review the role of PROMs in pediatrics.
  • To examine the integration of PROMs within value-based medicine.

Main Methods:

  • Literature review on PROMs in pediatrics and value-based medicine.
  • Analysis of current implementation strategies and measurement tools.
  • Discussion of the impact on personalized healthcare delivery.

Main Results:

  • PROMs are integral to value-based healthcare, enhancing patient-centeredness.
  • Effective PROM implementation requires updated, validated tools within a self-learning ecosystem.
  • PROMs in pediatrics can improve personalized care and community health.

Conclusions:

  • PROMs are key to achieving value-based medicine in pediatrics.
  • Well-implemented PROMs support enhanced personalized healthcare delivery.
  • Integrating PROMs contributes to improving overall community health outcomes.

Keywords:
Paediatrics and child healthpatient-reported outcome measuresvalue-based medicine and care

More Related Videos

Whole-body PET/MRI of Pediatric Patients: The Details That Matter10:02

Whole-body PET/MRI of Pediatric Patients: The Details That Matter

Published on: December 19, 2017

14.8K
Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus06:15

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus

Published on: March 6, 2019

50.8K

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
31
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
35
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
37
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
201
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
3.3K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
38